Understanding pain in women with polyendocrine metabolic ovarian syndrome: health risks and treatment effectiveness.

Over 20% of women with PMOS experience pain, with prevalence reaching 33% among Black or African American women, highlighting significant health disparities.

• Why it matters: Pain in women with PMOS is underexplored, yet it significantly impacts health outcomes and quality of life, emphasizing the need for better understanding and management strategies.
• What they did: Analyzing electronic health records from over 100 million women, the study assessed pain prevalence, associated health risks, racial differences, and the effects of PMOS-related medications on pain symptoms.
• The result: Women with PMOS and pain face higher risks of conditions like ovarian cysts and mental health issues, and treatment reduces pain, underscoring the importance of routine pain management and personalized care.